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Abstract 
Background: Glaucoma patients often come with intraocular pressure (IOP) that 
reach target pressure, but still have glaucoma progression due to IOP fluctuation. 
Water drinking test (WDT) can be used as a method to predict IOP fluctuation.  
Purpose: To compare prostaglandin analogue (PGA) and selective laser 
trabeculoplasty (SLT) capability to maintain IOP fluctuation on primary open 
angle glaucoma (POAG). 
Method: This clinical experimental research was conducted at Dr. Kariadi 
Hospital. Subjects were POAG patients selected with consecutive sampling. 
Intraocular pressure was measured before and after WDT. After WDT, IOP was 
measured every 15 minutes until 1 hour. Peak IOP and IOP fluctuation data were 
collected then analyzed with t-test.  
Results: Forty two eyes from 30 POAG patients were analyzed. Twenty six eyes 
in PGA group and 16 eyes in SLT group. Most of the subjects were male with mild 
glaucoma degree. WDT increased IOP significantly on both groups. Mean IOP pre 
WDT was 14.58 ± 2.580 mmHg and 16.94 ± 2.645 mmHg in PGA and SLT 
groups. Mean peak IOP post WDT was 22.73 ± 4.114 mmHg and 25.75 ± 5.859 
mmHg in PGA and SLT groups. Mean IOP fluctuation was 8.15 ± 4.202 mmHg 
and 8.81 ± 5.344 mmHg in PGA and SLT groups. Peak IOP and IOP fluctuation 
result analysis on both groups were not significantly different. 
Conclusion: Prostaglandin analogue and SLT had equal capability to maintain IOP 
fluctuation but still higher than normal fluctuation (> 6 mmHg) that may affects 
glaucoma progression. 
 
Keywords: Primary open angle glaucoma, prostaglandin analogue, selective laser 
trabeculoplasty water drinking test. 
 
INTRODUCTION 
 Glaucoma represents a group of diseases defined 
by a characteristic optic neuropathy that is consistent 
with excavation and undermining of the neural and 
connective tissue elements of the optic disc and by 
the eventual development of distinctive patterns of 
visual dysfunction.
1
 As many as 13,4% of blind 
people in Indonesia suffered from glaucoma.
2
 
Elevated intraocular pressure (IOP) is one of primary 
risk factors of glaucoma progression. 
 Glaucoma patients often come to the clinic with 
IOP that reach target pressure, but still have glaucoma 
progression. Twenty-four hours IOP fluctuation 
affects glaucoma progression.
3
 The current goal of 
glaucoma therapy is reaching target IOP with 
minimal IOP fluctuation to prevent glaucoma 
progression. Kumar et al said water drinking test 
(WDT) can be used as an alternative method to 
measure peak IOP and IOP fluctuation when patients 
come to the clinic.
4 
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 Prostaglandin analogue (PGA) is currently first 
line drug for primary open angle glaucoma (POAG) 
that can reduce IOP by 25-32%. Another therapy for 
POAG is selective laser trabeculoplasty (SLT) that 
can reduce IOP by 20-25%.
1
   
 Lately, SLT not only used for patients who have 
maximum tolerance to medical therapy but also used 
for initial therapy of glaucoma. This study aim to 
compare PGA and SLT ability to maintain IOP 
fluctuation on POAG patients.   
 
METHODS 
 This study was conducted at Dr. Kariadi Hospital 
from August 2016 until February 2017. Populations 
of study were POAG patients, which were diagnosed 
based on gonioscopy examination (open angle), 
funduscopy examination (cup and disc ratio > 0.3 
with glaucomatous excavation, and medialization), 
the presence of visual field defect based on 
Humphrey perimetry with MD ≥-6dB within one last 
year, and had optic nerve and retinal nerve fiber layer 
(RNFL) thickness OCT examinations within one last 
year. Glaucoma degree was determined by an average 
of RNFL thickness. Intervention consist of PGA 
therapy (latanoprost or travoprost) and 360
0
  SLT 
therapy of trabecular meshwork done by same 
surgeon. Length of therapy before reaching target IOP 
was not considered in this study. Samples of study 
were 30 POAG patients who fulfilled inclusion and 
exclusion criteria.  
 Inclusion criteria were 40-69 years old POAG 
patients who had reach IOP target pressure.  
 
Table 1.Glaucoma Degree Assessment based 
onAverage RNFL Thickness
5 
 
Average 
RNFL 
Thickness 
Glaucoma Degree 
>80 µm Normal 
70-79 µm Borderline, glaucoma suspect 
60-69 µm Early thinning, early glaucoma 
50-59 µm Moderate thinning, moderate 
glaucoma 
40-49µm Advanced thinning, advanced 
glaucoma 
<30µm Advanced thinning, primary 
retinal disease 
  
Patients were classified based on target pressure for 
POAG using European Glaucoma Society (2003) 
guidelines as follows:
6
 
 Early glaucoma: < 18 mmHg 
 Moderate glaucoma: < 15 mmHg 
 Advanced glaucoma: < 12 mmHg 
 End-stage glaucoma: < 10 mmHg 
 
 Exclusion criteria consist of previous intraocular 
surgery (ex. cataract extraction, trabeculectomy 
surgery, etc), the presence of corneal defect, and 
systemic diseases (ex. congestive heart failure and 
renal disease).  
 Water drinking test (WDT) was used to predict 
peak IOP and IOP fluctuation. Ppatients were asked 
to drink 1,000 ml mineral water within 10 minutes. 
Intraocular pressure was measured before WDT and 
subsequently at 15 minutes, 30 minutes, 45 minutes, 
and 60 minutes. Peak of IOP and IOP fluctuation  
were analyzed by SPSS.   
RESULTS 
 Research subjects were POAG patients that 
divided into PGA group and SLT group. PGA group 
consist of 26 eyes from 19 patients, while SLT group 
consist of 16 eyes from 11 patients. Selective laser 
trabeculoplasty group had fewer patients than PGA 
group due to laser equipment error since November 
2016. Mean age in PGA group was 58.79±6.40 years, 
while in SLT group was 53.82±7.74 years (table 2).  
 Saphiro-Wilk test for PGA group showed all of 
data distributed normally. T-test IOP pre and post 
WDT (15 minutes, 30 minutes, 45 minutes, 60 
minutes) in PGA group showed p value <0.05 in all 
pair data (table 4). 
 Saphiro-Wilk test for SLT group showed most 
data distributed normally, except IOP post WDT 60 
minutes. T-test IOP pre and post WDT (15 minutes, 
30 minutes, 45 minutes, 60 minutes) in SLT group 
showed p value < 0.05 in all pair data (table 5). 
 Independent t-test was performed to analyze most 
PGA and SLT data, except in IOP post WDT 60 
minutes (using Mann Whitney test) because the data 
was not distributed normally. The result of the 
statistical analysis showed IOP pre WDT, post WDT 
30 minutes, 45 minutes, and 60 minutes were 
significantly different between PGA and SLT group 
with p value < 0.05 (table 6). 
 
  
Table 3. Demographic Data of Subjects based on 
Glaucoma Degree 
 
 
Giving PGA or SLT as monotherapy for 
glaucoma patients only fulfilled target pressure in 
mild degree glaucoma. Most of the subject of both 
group had mild degree of glaucoma, 96.2% in PGA 
group and 75.0% in SLT group (Table 3). 
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Table 4. Water Drinking Test Result in PGA 
Group 
 
 N Mean IOP ± 
SD 
(mmHg) 
IOP 
Min 
(mmHg) 
IOP 
Max 
mmHg) 
Pre WDT 26 14.58 ± 2.580 10 20 
15 minutes 26 20.50 ± 4.366 14 28 
30 minutes 26 19.69 ± 4.873 11 28 
45 minutes 26 19.15 ± 5.746 8 30 
60 minutes 26 18.58 ± 5.457 8 30 
Peak 26 22.73 ± 4.114 14 30 
Fluctuation 26 8.15 ± 4.202 0 16 
 
Table 5. Water Drinking Test Result in SLT Group 
 
 N Mean IOP ± 
SD 
(mmHg) 
IOP Min 
(mmHg) 
IOP Max 
(mmHg) 
Pre WDT 16 16.94 ± 2.645 12 20 
15 minutes 16 22.31 ± 5.082 14 31 
30 minutes 16 24.31 ± 6.183 13 35 
45 minutes 16 23.00 ± 5.820 13 33 
60 minutes 16 23.19 ± 5.319 13 29 
Peak 16 25.75 ± 5.859 15 35 
Fluctuation 16 8.81 ± 5.344 0 16 
 
 Paired t-test on both group showed IOP pre and 
post WDT were significantly different  
in all WDT pairs. This result showed that WDT 
raised IOP significantly on both group.  
Peak IOP in PGA group appeared after 15 minutes 
post WDT, while in SLT group after 30 minutes. 
 
Table 6. Statistical Analysis IOP Pre and Post Water 
Drinking Test between Prostaglandin Analogue and  
Selective Laser Trabeculoplasty Group 
 
 PGA Group 
(Mean ± SD) 
mmHg 
SLT Group 
(Mean ± SD) 
mmHg 
p 
Pre WDT 14.58 ± 2.580 16.94 ± 2.645 0.007*1 
15 minutes 20.50 ± 4.366 22.31 ± 5.082 0.2271 
30 minutes 19.69 ± 4.873 24.31 ± 6.183 0.010*1 
45 minutes 19.15 ± 5.746 23.00 ± 5.820 0.042*1 
60 minutes 18.58 ± 5.457 23.19 ± 5.319 0.011*2 
Peak 22.73 ± 4.114 25.75 ± 5.859 0.0571 
Fluctuation 8.15 ± 4.202 8.81 ± 5.344 0.6591 
 
Statistical analysis showed that PGA and SLT 
group were significantly different at pre WDT, post 
WDT 30 minutes, 45 minutes, and 60 minutes with p 
value < 0.05. This results showed the IOP different of 
two groups since before WDT, at 30 minutes, 45 
minutes, and 60 minutes post WDT. 
Meanwhile, both group showed IOP post WDT 
15 minutes were not significantly different. It could 
happen because IOP raise continuously between two 
groups at 15 minutes. 
Mean peak of IOP in PGA group was 22.73 ± 4.114 
mmHg, while in SLT group was 25.75 ± 5.859 
mmHg. Mean IOP fluctuation in PGA group was 8.15 
± 4.202 mmHg (55.90% ± 28.22%), while in SLT 
group was 8.81 ± 5.344 mmHg (52.01% ± 31.55%). 
 
 
 
Figure 1. Graphic of Statistical Analysis Mean IOP 
Pre and Post Water Drinking Test between PGA and 
SLT Group 
 
 When observing presented value by the statistic, it 
appeared there was a considerable difference in peak 
IOP between PGA and SLT group, but statistical 
analysis result indicated that peak of IOP and IOP 
fluctuation between two groups were not significantly 
different. This could be influenced by significantly 
different mean IOP pre WDT that affected peak IOP 
on both group. It could be concluded that both PGA 
and SLT had equal potency to control IOP 
fluctuation. 
 Nagar et al
6
 found that an IOP reduction after 
treated with latanoprost and SLT 360˚ were not 
significantly different. Intraocular pressure reduction 
after treated with latanoprost was >20% in 90% eyes, 
and >30% in 78% eyes. While IOP reduction after 
treated with SLT 360˚ was >20% in 82% eyes, and 
>30% in 59% eyes. The IOP reduction between two 
groups was not significantly different. 
 Katz LJ et al
7
 also found that IOP reduction 
between PGA group and SLT group were similar 
after 9-12 months follow up. Mean IOP reduction in 
PGA group was 7.0 mmHg, while in SLT group was 
6.3 mmHg. Both Nagar et al
6
 and Katz LJ et al 
concluded IOP reduction after treated with PGA and 
SLT were not significantly different . 
 Nagar et al
8
 and Kiddee et al
9
 studied IOP 
fluctuation after treatment of PGA and SLT. Based on 
Nagar et al
8
 study, SLT and latanoprost had 
significant effect on IOP reduction and IOP 
fluctuation, but latanoprost more capable on reducing 
IOP fluctuation. Intraocular fluctuation reduction was 
50% in SLT group, and 83% in latanoprost group 
after 4-6 months follow up.  
 Kiddee et al
9
 study showed that travoprost and 
SLT could significantly reduced IOP in POAG 
patients. Travoprost was more capable in controlling 
IOP fluctuation than SLT especially at daytime. 
During nighttime, both of travoprost and SLT could 
significantly control IOP fluctuation. 
 This study result concluded both therapy had 
equal potency to control IOP fluctuation, which was 
different with uther studies. It could be caused by age 
16 
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different of the subjects that influenced patient 
response to therapy. In Kiddee et al
9
 study, mean age 
of the patients in travoprost group was 62.3 ± 13.1 
years, while in SLT group was 68.0 ± 10.0 years. In 
this study, mean age of patients in PGA group was 
58.79 ± 6.40 years, while in SLT group was 53.82 ± 
7.74 years.  
 Nagar et al
8
 observed the diurnal curve after 4-6 
months follow up of treatment, while this study was 
at point prevalence using cross sectional design. The 
different number of subjects between PGA and SLT 
group in this study could cause different result with 
previous study. 
 Water drinking test were raised an IOP 
significantly on both group. Therefore both PGA and 
SLT could not prevent IOP fluctuation until normal 
(2-6 mmHg). However, mean of IOP fluctuation on 
both groups were lower than IOP fluctuation on 
glaucoma patients without therapy ( ≥10mmHg).1 
 There were some limitations in this study 
including short period of study, different number of 
subjects between two groups, the subjects could not 
represent all of glaucoma degree, no equal period of 
fasting, no diet recall, and different diurnal time of 
performing WDT. Besides, there was significantly 
different IOP pre WDT between two groups that 
caused difference of peak IOP although not 
significantly different.  
 
CONCLUSION 
 There was no significant difference of WDT result 
(IOP fluctuation) on POAG patients treatment with 
PGA and with SLT. Prostaglandin Analogue and SLT 
had equal capability to maintain IOP fluctuation but 
still higher than normal fluctuation (> 6 mmHg). 
Prostaglandin analogue or SLT as monotherapy of 
POAG cannot control IOP normal fluctuation. 
Additional therapy or combination therapy is required 
to reach normal IOP fluctuation. 
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